Activity value 70somalia Buyer,Last transaction date:
2023-03-22
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for ajmal pharmaceutical co.ltd. from 2022 to 2023.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2023, the company has completed 10 transactions, with a transaction quantity of 2386 and a transaction weight of 97.
YearTransactionsQuantityWeight
202251266430
202310238697
Bill of lading data
<
1/15
>
Trade date
2023/03/22
B/L No.
23343100ex00064250
Suppliers
sina ecza deposu anonim şirketi
Buyers
ajmal pharmaceutical co.ltd.
POLs
ambarli
PODs
——
Supply area
Turkey
Purchas area
Somalia
Weight
6.25kg
Amount
247.05
Hs code
300490000000
Product tags
pro
Product description
PROCTO-GLYVENOL 400+40 MG 10 S
Expand
Trade date
2023/03/22
B/L No.
23343100ex00064250
Suppliers
sina ecza deposu anonim şirketi
Buyers
ajmal pharmaceutical co.ltd.
ajmal pharmaceutical co.ltd. is somalia Buyer,
and primarily engages in the import and export business of products such as bat,kit,pharma product.
According to the 52wmb.com global trade database, as of 2023-03-22, the company has completed 1185 international trades,
with its main trading regions covering india,turkey etc.
The core products include HS30049099,HS300490000000,HS30029090 etc,
often transported via mogadischu etc,
and its main trading partners are saintroy lifescience,abay ecza deposu sanayi ve ticaret,tribhuvan pharma.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on ajmal pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.